[1]
N. Foroutan, F. Fahimi, Y. Dabiri, A. Foroutan, M. Habibi, and J. Salamzadeh, “BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS”, J Popl Ther Clin Pharmacol, vol. 22, no. 3, Nov. 2018, Accessed: Nov. 19, 2024. [Online]. Available: https://mail.jptcp.com/index.php/jptcp/article/view/244